Practical Aspects of Implementation of Helical Tomotherapy for Intensity-modulated and Image-guided Radiotherapy

被引:48
|
作者
Burnet, N. G. [1 ]
Adams, E. J. [2 ]
Fairfoul, J. [2 ]
Tudor, G. S. J. [2 ]
Hoole, A. C. F. [2 ]
Routsis, D. S. [3 ]
Dean, J. C. [3 ]
Kirby, R. D. [3 ]
Cowen, M. [2 ]
Russell, S. G. [3 ]
Rimmer, Y. L. [3 ]
Thomas, S. J. [2 ]
机构
[1] Univ Cambridge, Dept Oncol, Ctr Oncol, Addenbrookes Hosp, Cambridge CB2 0QQ, England
[2] Addenbrookes Hosp, Dept Med Phys, Cambridge, England
[3] Addenbrookes Hosp, Ctr Oncol, Cambridge, England
关键词
Helical tomotherapy; image-guided intensity-modulated radiotherapy; COMPUTED-TOMOGRAPHY IMAGES; LOCALIZED PROSTATE-CANCER; RADIATION-THERAPY; CLINICAL IMPLEMENTATION; CONVENTIONAL RADIOTHERAPY; CONFORMAL RADIOTHERAPY; QUALITY-ASSURANCE; TARGET COVERAGE; DOSE-ESCALATION; GUIDANCE;
D O I
10.1016/j.clon.2010.02.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: Image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) represent two important technical developments that will probably improve patient outcome. Helical tomotherapy, provided by the TomoTherapy HiArt (TM) system, provides an elegant integrated solution providing both technologies, although others are available. Here we report our experience of clinical implementation of daily online IGRT and IMRT using helical tomotherapy. Materials and methods: Methods were needed to select patients who would probably benefit. Machine-specific commissioning, a quality assurance programme and patient-specific delivery quality assurance were also needed. The planning target volume dose was prescribed as the median dose, with the added criterion that the 95% isodose should cover 99% of the target volume. Although back-up plans, for delivery on conventional linear accelerators, were initially prepared, this practice was abandoned because they were used very rarely. Results: In the first 12 months, 114 patients were accepted for treatment, and 3343 fractions delivered. New starts averaged 2.6 per week, with an average of 17.5 fractions treated per day, and the total number capped at 22. This has subsequently been raised to 24. Of the first 100 patients, 96 were treated with radical intent. Five were considered to have been untreatable on our standard equipment. IGRT is radiographer led and all patients were imaged daily, with positional correction made before treatment, using an action level of 1 mm. A formal training programme was developed and implemented before installation. The in-room time fell significantly during the year, reflecting increasing experience and a software upgrade. More recently, after a couch upgrade in April 2009, the mean in-room time fell to 18.6 min. Conclusions: Successful implementation of tomotherapy was the result of careful planning and effective teamwork. Treatment, including daily image guidance, positional correction and intensity-modulated delivery, is fast and efficient, and can be integrated into routine service. This should encourage the adoption of these technologies. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:294 / 312
页数:19
相关论文
共 50 条
  • [1] Workload of breast image-guided intensity-modulated radiotherapy delivered with TomoTherapy
    Rosalinda, Ricotti
    Eleonora, Miglietta
    Cristina, Leonardi Maria
    Federica, Cattani
    Samantha, Dicuonzo
    Patricia, Rojas Damaris
    Giulia, Marvaso
    Roberto, Orecchia
    Alicjala, Jereczek-Fossa Barbara
    TUMORI JOURNAL, 2020, 106 (06): : 518 - 523
  • [2] Dose escalation in image-guided, intensity-modulated radiotherapy of carcinoma prostate: Initial experience in India
    Swamy, Kumara
    Narayanan, V. K. Sathiya
    Basu, Sumeet
    Maiya, Vikram
    Achari, Rimpa
    Deshpande, Shrikant
    Bhangle, Janhavi
    Gupta, Kamlesh Kumar
    Babu, Nirmal
    Pawar, Surendra
    Atre, Ashish
    Balachandra, Kashyapi
    Koppiker, C. B.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2009, 5 (04) : 277 - 283
  • [3] Helical tomotherapy: Image-guided intensity modulated radiation therapy
    Keum, Ki Chang
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2008, 51 (07): : 619 - 629
  • [4] Re-irradiation of unresectable recurrent head and neck cancer: using Helical Tomotherapy as image-guided intensity-modulated radiotherapy
    Jeong, Songmi
    Yoo, Eun Jung
    Kim, Ji Yoon
    Han, Chi Wha
    Kim, Ki Jun
    Kay, Chul Seung
    RADIATION ONCOLOGY JOURNAL, 2013, 31 (04): : 206 - 215
  • [5] Helical Tomotherapy: Image-Guided and Adaptive Radiotherapy
    Kupelian, Patrick
    Langen, Katja
    IMRT IGRT SBRT- ADVANCES IN THE TREATMENT PLANNING AND DELIVERY OF RADIOTHERAPY, 2011, 43 : 165 - 180
  • [6] The value of image-guided intensity-modulated radiotherapy in challenging clinical settings
    Treece, S. J.
    Mukesh, M.
    Rimmer, Y. L.
    Tudor, S. J.
    Dean, J. C.
    Benson, R. J.
    Gregory, D. L.
    Horan, G.
    Jefferies, S. J.
    Russell, S. G.
    Williams, M. V.
    Wilson, C. B.
    Burnet, N. G.
    BRITISH JOURNAL OF RADIOLOGY, 2013, 86 (1021)
  • [7] A review of image-guided intensity-modulated radiotherapy for spinal tumors
    Yamada, Yoshiya
    Lovelock, D. Michael
    Bilsky, Mark H.
    NEUROSURGERY, 2007, 61 (02) : 226 - 235
  • [8] Image-guided intensity modulated radiotherapy with helical tomotherapy for postoperative treatment of high-risk oral cavity cancer
    Hsieh, Chen-Hsi
    Kuo, Ying-Shiung
    Liao, Li-Jen
    Hu, Kawang-Yu
    Lin, Shih-Chiang
    Wu, Le-Jung
    Lin, Yu-Chin
    Chen, Yu-Jen
    Wang, Li-Ying
    Hsieh, Yen-Ping
    Lin, Shoei Long
    Chen, Chun-Yi
    Chen, Chien-An
    Shueng, Pei-Wei
    BMC CANCER, 2011, 11
  • [9] Stereotactic image-guided intensity modulated radiotherapy using the HI-ART II helical tomotherapy system
    Holmes, Timothy W.
    Hudes, Richard
    Dziuba, Sylwester
    Kazi, Abdul
    Hall, Mark
    Dawson, Dana
    MEDICAL DOSIMETRY, 2008, 33 (02) : 135 - 148
  • [10] High-Dose-Rate Brachytherapy Monotherapy versus Image-Guided Intensity-Modulated Radiotherapy with Helical Tomotherapy for Patients with Localized Prostate Cancer
    Yamazaki, Hideya
    Masui, Koji
    Suzuki, Gen
    Nakamura, Satoaki
    Shimizu, Daisuke
    Nishikawa, Tatsuyuki
    Okabe, Haruumi
    Yoshida, Ken
    Kotsuma, Tadayuki
    Tanaka, Eiichi
    Otani, Keisuke
    Yoshioka, Yasuo
    Ogawa, Kazuhiko
    CANCERS, 2018, 10 (09)